Genenta Science
GNTA
2 hedge funds and large institutions have $517K invested in Genenta Science in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.26% more ownership
Funds ownership: 0% → 0.26% (+0.26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AU
Algebris (UK)
London,
United Kingdom
|
+$510K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$24.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AU
1
Algebris (UK)
London,
United Kingdom
| $493K | +$510K | +45,000 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $24K | +$24.5K | +2,163 | New |
|
GNTA Hedge Fund Activity: Q4 2021 in Review
2 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q4 2021, worth a combined $517K.
Buyers outnumbered sellers: 2 funds opened new GNTA positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Algebris (UK), opening a new position worth an estimated $510K.
- 2 institutional investors held Genenta Science (GNTA) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $517K of Genenta Science stock for Q4 2021.
- 2 funds opened new Genenta Science positions in Q4 2021 and 0 closed out, a net change of +2 holders.
- The largest Genenta Science buyer in Q4 2021 was Algebris (UK), an estimated $510K added.
Based on aggregated 13F filings for Q4 2021.